FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹200 Cr | ₹318 Cr | ₹221 Cr | ₹155 Cr | ₹162 Cr |
What is the latest Cash Flow from Operating Activities ratio of FDC ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹200 Cr |
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹155 Cr |
| Mar2022 | ₹162 Cr |
How is Cash Flow from Operating Activities of FDC Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹200 Cr | -36.88 | |
| Mar2025 | ₹318 Cr | 43.85 | |
| Mar2024 | ₹221 Cr | 42.51 | |
| Mar2023 | ₹155 Cr | -4.17 | |
| Mar2022 | ₹162 Cr | - | |
Compare Cash Flow from Operating Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,376.1 Cr | 3.7% | 17.9% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 3.7% |
17.9% |
-11.8% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses